mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.04 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.04 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.14 |
0.04 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.04 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |